Literature DB >> 10834493

Adjunctive 3D US for achieving portal vein access during transjugular intrahepatic portosystemic shunt procedures.

S C Rose1, D H Pretorius, T R Nelson, T B Kinney, T V Huynh, A C Roberts, K Valji, H R D'Agostino, S B Oglevie, G M James, T I Hassanein, M E Hart, M J Orloff.   

Abstract

PURPOSE: To evaluate the usefulness of information provided by three-dimensional ultrasound (3D US) and to determine whether 3D US decreased the number of passes required to obtain portal vein (PV) access during creation of transjugular intrahepatic portosystemic shunts (TIPS).
MATERIALS AND METHODS: Intermittent 3D US volume acquisitions were obtained during creation of TIPS in 20 patients. Useful information provided by 3D US was tabulated. The number of passes required to achieve PV access was recorded and results were compared retrospectively to 25 patients who underwent TIPS without 3D US.
RESULTS: 3D US documented that the operator's opinion of which hepatic vein had been selected was incorrect in nine patients (45%), detected unfavorable PV anatomy that required modification of equipment or technique in seven patients (35%), permitted estimation of the trajectory required to access the targeted PV in all patients (100%), assisted in selecting the optimal point along the hepatic vein for origination of the needle pass in 11 patients (55%), allowed avoidance of a large hepatocellular carcinoma in one patient (5%), and confirmed that access into the main PV was intrahepatic in four patients (20%). The mean number of needle passes decreased from 10.4 in the historic control group to 4.6 in the 3D US group (P = .0001).
CONCLUSION: 3D US provided imaging information that detected technical errors and altered anatomy, and provided positional and directional information to significantly improve needle pass efficiency.

Entities:  

Mesh:

Year:  2000        PMID: 10834493     DOI: 10.1016/s1051-0443(07)61614-5

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

1.  The difficult transjugular intrahepatic portosystemic shunt: alternative techniques and "tips" to successful shunt creation.

Authors:  Hector Ferral; Jose Ignacio Bilbao
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

2.  Transjugular intrahepatic portosystemic shunt creation: three-dimensional roadmap versus CO2 wedged hepatic venography.

Authors:  Xuefeng Luo; Xiaoze Wang; Jiaze Yu; Yongjun Zhu; Xiaotan Xi; Huaiyuan Ma; Li Yang
Journal:  Eur Radiol       Date:  2018-02-19       Impact factor: 5.315

Review 3.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02

4.  Imaging detection of new HCCs in cirrhotic patients treated with different techniques: Comparison of conventional US, spiral CT, and 3-dimensional contrast-enhanced US with the Navigator technique (Nav 3D CEUS)().

Authors:  F Giangregorio; G Comparato; M G Marinone; M Di Stasi; G Sbolli; G Aragona; P Tansini; F Fornari
Journal:  J Ultrasound       Date:  2009-02-26

5.  Vessel target location estimation during the TIPS procedure.

Authors:  Guillaume Piliere; Mark H Van Horn; Robert Dixon; Joseph Stavas; Stephen Aylward; Elizabeth Bullitt
Journal:  Med Image Anal       Date:  2009-03-05       Impact factor: 8.545

6.  Contrast-Enhanced Ultrasound (CEUS) for Echographic Detection of Hepato Cellular Carcinoma in Cirrhotic Patients Previously Treated with Multiple Techniques: Comparison of Conventional US, Spiral CT and 3-Dimensional CEUS with Navigator Technique (3DNav CEUS).

Authors:  Francesco Giangregorio
Journal:  Cancers (Basel)       Date:  2011-03-30       Impact factor: 6.639

7.  Interventional procedures in superficial lesions: the value of 2D with additional coronal reformatted 4D ultrasonography guidance.

Authors:  Cheng-Yen Chang; Hsin-Kai Wang; Hong-Jen Chiou; Yi-Hong Chou; Tain-Hsiung Chen; See-Ying Chiou
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.